Description
Glucocorticoid receptor agonist-4 (Compound Preparation 5) is a glucocorticoid receptor agonist that can be conjugated to TNF-α antibodies for the study of autoimmune and inflammatory diseases[1].–20°C (Powder, sealed storage, away from moisture and light)-Applications-COVID-19-immunoregulation-Formula-C36H40FNO7-Citation–References-[1]Grace CHAO, et al. Human tumor necrosis factor alpha antibody glucocorticoid conjugates. Patent WO2023220549A1.-CASNumber-2842165-72-2-MolecularWeight-617.70-Compound Purity-99.80-SMILES-OCC([C@]12[C@@]3([C@@]([C@@]4([H])[C@]([C@@]5(C(CC4)=CC(C=C5)=O)C)([H])[C@H](C3)O)([H])C[C@@]1([H])O[C@@H](C6=C(C(OCC7=CC(N)=CC=C7)=CC=C6C)F)O2)C)=O-Research_Area-Inflammation/Immunology-Solubility-DMSO : 200 mg/mL (ultrasonic)-Target-ADC Cytotoxin;Glucocorticoid Receptor-Isoform–Pathway-Antibody-drug Conjugate/ADC Related;Immunology/Inflammation;Vitamin D Related/Nuclear Receptor-MCE Product type-ADC Related
